Scenario 1: Diagnostic No PCI Required

Slides:



Advertisements
Similar presentations
SPIRIT IV A Prospective, Randomized Trial Comparing an Everolimus-Eluting Stent and a Paclitaxel-Eluting Stent in Patients with Coronary Artery Disease.
Advertisements

The value of DES in unprotected left main lesions has not been evaluated by dedicated randomized clinical trials. Especially, it is not known whether currently.
Bifurcation LAD/D2 lesion. Provisional T stenting.
 An angiographic tool grading the complexity of coronary artery disease  A semiquantitative visual score that will help us to be aware of the anatomical.
Bifurcation stenting. Crush technique. LAD / Diagonal 68 yr old male
FRACTIONAL FLOW RESERVE versus ANGIOGRAPHY
CORONARY PRESSURE MEASURENT AND FRACTIONAL FLOW RESERVE
The Effect of Coronary Arteries diameter on the Incidence of Postoperative Atrial Fibrillation.
Chaim Lotan MD, Yaron Almagor MD, Karel Kuiper MD, M.J. Suttorp MD, William Wijns MD The SICTO Study CYPHER TM Sirolimus-eluting stent in Chronic Total.
FFR in specific circumstances Zsolt Piróth MD Gottsegen György Hungarian Institute of Cardiology.
5F in 6F (7F) technique in DES era (Parent-child catheter technique)
Unstable angina and arterial hypertension Leszek Kinasz, MD American Heart of Poland Ustron, Poland.
TRANSRADIAL ROTABLATION OF A CASE OF CTO Dr. Christian Pristipino Coronary Intervention Unit San Filippo Neri Hospital Rome, Italy.
Featuring CTO Complex-PCI by Trans-radial Approach CTO Case review 5 French TRI CTO of right coronary artery -5 F Launcher guiding Catheter (right Judkins.
Pressure Wire Evaluation of the Left Main Stem Dr Phil MacCarthy Consultant Cardiologist King’s Cardiac Centre Left Main 5+ at AA2007, Jan 24 th, 2007.
Fu Wai Hospital Jie Qian
The First Affiliated Hospital of Harbin Medical University
Using a deflectable tipped Catheter to treat previously inaccessible lesions Helen Routledge Interventional Fellow Institut Cardiovasculaire Paris Sud.
PCI from native vessel disease or bypass vessel disease post CABG Nanjing first hospital Yefei Chenshaoliang.
Date of download: 7/9/2016 Copyright © The American College of Cardiology. All rights reserved. From: Severe Neointimal Hyperplasia of Neoplastic Carina.
M-Guard stent in STEMI patients with high thrombus burden lesions Mahmoud Shabestari Baktash Bayani Ali Eshraghi Bahram Shahri Mashhad University.
LipiScan IVUS Coronary Imaging System
The OPTIMAX first-in-man study Mid-term clinical outcome of Titanium-Nitride-Oxide-coated Cobalt Chromium stents in patients with de novo coronary artery.
Lipid-Rich Plaque Study
A new technique of IVUS guided CTO PCI
Ospedale San Raffaele, Milan, Italy
Takashi Ashikaga,MD,PhD
It’s Both the Vulnerable Patient and the Vulnerable Plaque
ST-segment elevation myocardial infarction in a patient with anomalous origin of left circumflex coronary artery  Masahiro Yamamoto, MD, Kenichi Tsujita,
Fractional Flow Reserve Evaluation in Patients Considered for Transfemoral Transcatheter Aortic Valve Implantation: A Case Series Cardiology 2012;123:234–239.
Interesting Case Presentation
Percutaneous Coronary Interventions for Patients with Relative Contra-indications: Severely Depressed Left Ventricular Function Great Wall International.
Clinical Presentation
Fig. 1. Initial coronary angiography reveals 70% narrowing of proximal LAD (A) and the stenosis is persistent after intracoronary nitrates administration.
Tarek Abou Ghazala, MD, FACC, FSCAI
Near-Infrared Spectroscopy: Lipid-Rich Plaque Study Update
Meruzhan Saghatelyan, MD, Interventional cardiologist
Near Infrared Spectroscopy: Case Studies and Clinical Relevance
Fig. 3. A 78-year-old male with chronic total occlusion in the proximal left anterior coronary artery (LAD) and procedure by retrograde wire crossing technique.
9:00 AM-9:05 AM, Tuesday, Oct. 31; Room 201/203
Intra-Aortic Balloon Pump For Complex Calcified Left-Main Bifurcation Lesion Supawat Ratanapo, MD Medical College of Georgia, Augusta University.
Physiological Assessment of Left Main Coronary Artery Disease
When IVUS? When FFR? Assessing Intermediate Lesions
BVS Expand: First Results of Wide Clinical Applications
Late stent thrombosis Ashish shah, Tim Kinnaird, W J Penny
PCI in patients with cardiogenic shock associated with acute occlusion of the left main coronary artery.
How to Build Your Own CTO PCI Program
OCT-Guided PCI What needs to be done to establish criteria?
The Hybrid approach to CTO PCI
Essesntials for CTO Recanalization
Fig. 2. Revascularization for CTO in RCA
Fractional Flow Reserve Workshop
Impact of calcium on procedural and clinical outcomes in lesions treated with bioresorbable vascular scaffolds - A prospective BRS registry study  Jiang.
Tareq Ibrahim et al. JIMG 2009;2:
Using Coronary CTA to Guide Intervention for CTO
Therapeutic angiogenesis with intramyocardial administration of basic fibroblast growth factor  Michio Kawasuji, MD, Hiroshi Nagamine, MD, Masahiro Ikeda,
SKS Technique Clinical Case
FFRangio Accuracy vs. STandard FFR: Results from the FAST-FFR Trial
SIRIUS: A U.S. Multicenter, Randomized, Double-Blind Study of the SIRolImUS-Eluting Stent in De Novo Native Coronary Lesions Presented at TCT 2002.
(a) Dyslipidaemia (b) Final MLD P = P = P = 0.972
Presented at TCT 2006.
Patient Examples of CMR Stress Test in Women Patient #1 is a 70-year-old, post-menopausal woman with typical angina and 3 coronary artery disease (CAD)
ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions J. Mehilli, MD Deutsches Herzzentrum Technische.
ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions J. Mehilli, MD Deutsches Herzzentrum Technische.
Ahmed A. Khattab, MD For the German Cypher Registry Investigators
DISTAL CORONARY ARTERY DISEASE
Eric A. Osborn, and Farouc A. Jaffer JIMG 2013;6:
Intraoperative Electroanatomic Mapping
DISTAL CORONARY ARTERY DISEASE
The Clinical Significance and Management Implications of Chronic Total Occlusion Associated With Surgical Coronary Artery Revascularization  Lorenzo Azzalini,
Presentation transcript:

Scenario 1: Diagnostic No PCI Required Left Coronary Artery (LCA) Right Coronary Artery (RCA) LCX 50mm RCA 65mm GC GC LAD 70mm Study Segment Qualifications: At least one Suspected Index Culprit Lesion (LAD) At least two major epicardial vessels eligible for IVUS-NIRS Imaging (RCA , LAD, LCX) At least 50mm total pullback (Visually estimated LAD 70mm pullback, LCX 50 mm pullback, RCA 65mm. Approximate total 185mm pullback of scanned coronary artery) Total Eligible Length (excludes stents & borders) = ~185mm Suspected Index Culprit Lesion: Prox LAD Unblinded Run: LAD Index Non-Culprit Artery: RCA, LCX Blinded Run(s): LCX, RCA PCI Performed: No PCI performed = Suspected Index Culprit Lesion = Blinded Scan = Guide Catheter = Unblinded Scan = 5mm excluded stent border = Treated Segment; scanned but not included in analysis XXXXX= Stent

Scenario 2: Single Lesion PCI GC LCA RCA LAD 45mm GC LCX 60mm RCA 50mm Total Eligible Length (excluding stent & borders) = ~155mm Suspected Index Culprit Lesion: RCA Unblinded Run: RCA Index Non-Culprit Artery: LAD, LCX Blinded Run(s): LCX, LAD PCI Performed On: Prox RCA XXXXX GC Study Segment Qualifications: At least one Suspected Index Culprit Lesion (RCA) At least two major epicardial vessels eligible for IVUS-NIRS Imaging (RCA , LAD, LCX) At least 50mm total pullback (Visually estimated LAD 45mm pullback, LCX 60 mm pullback, RCA 50mm. Approximate total 155mm pullback of scanned coronary artery) Exclude 5mm borders = Suspected Index Culprit Lesion = Blinded Scan = Guide Catheter = Unblinded Scan = 5mm excluded stent border = Treated Segment; scanned but not included in analysis XXXXX = Stent RCA 50mm

Scenario 3: Chronic Total Occlusion RCA GC LCA RCA GC CTO LAD 35mm LCX 55mm RCA GC Study Segment Qualifications: At least one Suspected Index Culprit Lesion (RCA) At least two major epicardial vessels eligible for IVUS-NIRS Imaging (LAD, LCX) At least 50mm total pullback (Visually estimated LAD 35mm pullback, LCX 55 mm pullback. Approximate total 90mm pullback of scanned coronary artery) Total Eligible Legth (exluding stents & borders) = ~90mm Suspected Index Culprit Lesion: RCA Unblinded Run: RCA Index Non-Culprit Artery: LAD, LCX Blinded Run(s): LCX, LAD PCI Performed On: Prox RCA RCA GC =Suspected Index Culprit Lesion = Blinded Scan XXXXXXXXXXX = Guide Catheter = Unblinded Scan Exclude 5mm borders = Treated Segment; scanned but not included in analysis = 5mm excluded stent border XXXXX = Stent

Scenario 4: Ramus Present LCA RCA LAD 45mm GC GC RCA 70mm LCX 55mm Ramus 20mm Study Segment Qualification: At least one Suspected Index Culprit Lesion (LCX) At least two major epicardial vessels eligible for IVUS-NIRS Imaging (RCA , LAD, LCX, Ramus) At least 50mm total pullback (Visually estimated LAD 45mm pullback, LCX 55 mm pullback, RCA 70mm, Ramus 20mm. Approximate total 190mm pullback of scanned coronary artery) Total Eligible Length (excluding stent & borders)= ~190mm Suspected Index Culprit Lesion: Prox LCX Unblinded Run: LCX Index Non-Culprit Artery: LAD, RCA, Ramus Blinded Run: LAD, RCA, Ramus PCI Performed On: No PCI performed = Suspected Index Culprit Lesion = Blinded Scan = Guide Catheter = Unblinded Scan = 5mm excluded stent border = Treated Segment; scanned but not included in analysis XXXXX = Stent

Scenario 5: Multi Lesion PCI LCA RCA GC GC Total Eligible Lengh (excluding stent & borders)= ~75mm Suspected Index Culprit Lesion: LAD, RCA Unblinded Run: LAD, RCA Index Non-Culprit Artery: Prox RCA Blinded Run: N/A PCI Performed On: Prox RCA and Prox/Mid LAD LAD 25mm RCA 50mm = Suspected Index Culprit Lesion Exclude 5mm borders Study Segment Qualifications: At least one Suspected Index Culprit Lesion (LAD, RCA) At least two major epicardial vessels eligible for IVUS-NIRS Imaging (RCA , LAD) At least 50mm total pullback (Visually estimated LAD 25mm pullback, RCA 50mm. Approximate total 75mm pullback of scanned coronary artery) Exclude 5mm borders = Unblinded Scan XXXXXX = Treated Segment; scanned but not included in analysis GC XXXXX LAD 25mm = Blinded Scan GC = Guide Catheter XXXXXX = 5mm excluded stent border RCA 50mm XXXXX = Stent

Scenario 6: Prior Stenting LCA RCA XXX GC GC LAD 35mm XXXXXXXXXXXXX Exclude 5mm borders RCA 15mm LCX 40mm Study Segment Qualifications: At least one Suspected Index Culprit Lesion (LAD, RCA) At least two major epicardial vessels eligible for IVUS-NIRS Imaging (RCA , LAD, LCX) At least 50mm total pullback (Visually estimated LAD 35mm pullback, RCA 15mm, LCX 40mm. Approximate total 90mm pullback of scanned coronary artery) Total Eligible Length (exluding stent & borders) = ~90mm Suspected Index Culprit Lesion: LAD, RCA Unblinded Run: LAD, RCA Index Non-Culprit Artery: LCX Blinded Run: LCX PCI Performed On: No PCI = Suspected Index Culprit Lesion = Blinded Scan = Guide Catheter = Unblinded Scan = 5mm excluded stent border = Treated Segment; scanned but not included in analysis XXXXX = Stent

Scenario 7: Single Lesion PCI and Ramus LCA RCA LAD Ramus 35mm RCA 80mm LCX 40mm LCX Total Eligible Length (excluding stent & borders)= ~180mm Suspected Index Culprit Lesion: LAD Unblinded Run: LAD Index Non-Culprit Artery: LCX, RCA, Ramus Blinded Run: LCX, RCA, Ramus PCI Performed On: Prox LAD Exclude 5mm borders LAD 25mm Study Segment Qualifications: At least one Suspected Index Culprit Lesion (LAD) At least two major epicardial vessels eligible for IVUS-NIRS Imaging (RCA , LAC, LCX) At least 50mm total pullback (Visually estimated LAD 25mm pullback, LCX 40 mm pullback, RCA 80mm, Ramus 35mm. Approximate total 180mm pullback of scanned coronary artery) XXXXX = Suspected Index Culprit Lesion = Blinded Scan Ramus 35mm = Guide Catheter = Unblinded Scan = 5mm excluded stent border LCX 40mm = Treated Segment; scanned but not included in analysis XXXXX= Stent